Company / Current Liabilities
Exelixis Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$405.6M
FY2025
5-year range
$324.4M / $405.6M
FY2021-FY2025
Trend
+0.5%
vs FY2024
Sector context
#39 of 213
Health Care
What the data says
Exelixis's current liabilities of $406M is higher than 82% of companies in the Health Care sector (FY2025). Current Liabilities has increased for 3 consecutive years, from $324M in FY2022 to $406M in FY2025.
Based on SEC 10-K filings.
$406M in FY2025 with a 5-year CAGR of +14.7%. Top quartile in the Health Care sector.
Increased from $394M to $406M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +7.7%
- 5-Year CAGR
- +14.7%
- 10-Year CAGR
- -
Sector benchmark
-74.5% below sector average
Key checks
Key Insights
- Exelixis's current liabilities has grown for 3 consecutive years.
- 5-year CAGR of +14.7%, indicating consistent growth.
- In FY2025, current liabilities increased 0.5% year-over-year.
- Ranks #39 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $405.6M | +0.5% |
| FY2024 | $403.8M | +2.4% |
| FY2023 | $394.3M | +21.6% |
| FY2022 | $324.4M | -3.9% |
| FY2021 | $337.6M | +65.0% |
| FY2020 | $204.7M | +43.4% |
| FY2019 | $142.7M | +35.3% |
| FY2018 | $105.5M | -8.4% |
| FY2017 | $115.2M | -57.2% |
| FY2016 | $268.8M | +414.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026